Drug safety profiles in geriatric patients with Parkinson’s disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug safety profiles in geriatric patients with Parkinson’s disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis
Authors
Keywords
-
Journal
JOURNAL OF NEURAL TRANSMISSION
Volume 128, Issue 1, Pages 49-60
Publisher
Springer Science and Business Media LLC
Online
2020-12-02
DOI
10.1007/s00702-020-02276-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Factors associated with hospitalisation among people with Parkinson's disease – A systematic review and meta-analysis
- (2020) Olaitan Okunoye et al. PARKINSONISM & RELATED DISORDERS
- Association of Motor and Cognitive Symptoms with Health-Related Quality of Life and Caregiver Burden in a German Cohort of Advanced Parkinson’s Disease Patients
- (2020) M. Klietz et al. Parkinsons Disease
- Self-Reported Nonadherence Predicts Changes of Medication after Discharge from Hospital in People with Parkinson’s Disease
- (2020) Francis Feldmann et al. Parkinsons Disease
- Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
- (2019) Klaus Seppi et al. MOVEMENT DISORDERS
- Systematic Literature Review of Quetiapine for the Treatment of Psychosis in Patients With Parkinsonism
- (2019) Jack J. Chen et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Potentially Inappropriate Prescribing and Related Hospital Admissions in Geriatric Patients: A Comparative Analysis between the STOPP and START Criteria Versions 1 and 2
- (2019) Stefanie Thevelin et al. DRUGS & AGING
- Safety and Tolerability of Pharmacotherapies for Parkinson’s Disease in Geriatric Patients
- (2019) Martin Klietz et al. DRUGS & AGING
- The FORTA (Fit fOR The Aged) List 2018: Third Version of a Validated Clinical Tool for Improved Drug Treatment in Older People
- (2019) Farhad Pazan et al. DRUGS & AGING
- Polypharmacy in Parkinson’s disease: risks and benefits with little evidence
- (2019) I. Csoti et al. JOURNAL OF NEURAL TRANSMISSION
- The U.S.-FORTA (Fit fOR The Aged) List: Consensus Validation of a Clinical Tool to Improve Drug Therapy in Older Adults
- (2019) Farhad Pazan et al. Journal of the American Medical Directors Association
- The Use of Benzodiazepine Receptor Agonists and the Risk of Hospitalization for Pneumonia
- (2018) Tien-Yu Chen et al. CHEST
- The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People
- (2018) Farhad Pazan et al. DRUGS & AGING
- Prevalence and Preventability of Drug-Related Hospital Readmissions: A Systematic Review
- (2018) Najla El Morabet et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
- (2018) Susan H. Fox et al. MOVEMENT DISORDERS
- Advances in Pharmacotherapy of Late-Life Depression
- (2018) John L. Beyer et al. Current Psychiatry Reports
- Multimorbidity patterns in the elderly: a prospective cohort study with cluster analysis
- (2018) Marina Guisado-Clavero et al. BMC Geriatrics
- Impaired Quality of Life and Need for Palliative Care in a German Cohort of Advanced Parkinson’s Disease Patients
- (2018) Martin Klietz et al. Frontiers in Neurology
- Potentially Inappropriate Medications in the Elderly
- (2018) Stefanie Holt et al. Deutsches Arzteblatt International
- Prevalence and Associated Factors of Sarcopenia and Frailty in Parkinson’s Disease: A Cross-Sectional Study
- (2018) Marina Peball et al. GERONTOLOGY
- Charakteristika und Dynamik der stationären Behandlung von Parkinson-Patienten in Deutschland
- (2018) L. Tönges et al. NERVENARZT
- Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis
- (2017) T. J. Oscanoa et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3)
- (2017) Wolfgang Oertel et al. MOVEMENT DISORDERS
- Morbus Parkinson im Alter
- (2017) Rüdiger Lange et al. ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
- VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification
- (2016) Martin Wehling et al. AGE AND AGEING
- Assessing and Measuring Chronic Multimorbidity in the Older Population: A Proposal for Its Operationalization
- (2016) Amaia Calderón-Larrañaga et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trial
- (2016) Joaquim J Ferreira et al. LANCET NEUROLOGY
- Benzodiazepine Use in Older Adults: Dangers, Management, and Alternative Therapies
- (2016) Matej Markota et al. MAYO CLINIC PROCEEDINGS
- Benzodiazepines and risk of death: Results from two large cohort studies in France and UK
- (2015) Aurore Palmaro et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Health-related quality of life in Parkinson’s disease: a cross-sectional study focusing on non-motor symptoms
- (2015) Liis Kadastik-Eerme et al. Health and Quality of Life Outcomes
- Comparative Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Older Adults: A Network Meta-Analysis
- (2015) Kristian Thorlund et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Relationship between the non-motor items of the MDS–UPDRS and Quality of Life in patients with Parkinson's disease
- (2015) Matej Skorvanek et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Nonpharmacological Interventions to Reduce Behavioral and Psychological Symptoms of Dementia: A Systematic Review
- (2015) Alexandra Martini de Oliveira et al. Biomed Research International
- Combined Rasagiline and Antidepressant Use in Parkinson Disease in the ADAGIO Study
- (2015) Kara M. Smith et al. JAMA Neurology
- Association between Benzodiazepine Use and Dementia: A Meta-Analysis
- (2015) GuoChao Zhong et al. PLoS One
- Drug-drug interaction software in clinical practice: a systematic review
- (2014) Tina Roblek et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease
- (2014) R. A. Hauser et al. EUROPEAN JOURNAL OF NEUROLOGY
- A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia
- (2014) Gill Livingston et al. HEALTH TECHNOLOGY ASSESSMENT
- Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease
- (2014) Rupam Borgohain et al. MOVEMENT DISORDERS
- Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's disease
- (2014) Robert A. Hauser et al. MOVEMENT DISORDERS
- Hospital admissions/visits associated with drug-drug interactions: a systematic review and meta-analysis
- (2014) Supinya Dechanont et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Serotonin Toxicity Association with Concomitant Antidepressants and Rasagiline Treatment: Retrospective Study (STACCATO)
- (2014) Michel Panisset et al. PHARMACOTHERAPY
- Consensus Validation of the FORTA (Fit fOR The Aged) List: A Clinical Tool for Increasing the Appropriateness of Pharmacotherapy in the Elderly
- (2013) Alexandra M. Kuhn-Thiel et al. DRUGS & AGING
- Efficacy of levodopa/carbidopa/entacapone versus levodopa/carbidopa in patients with early Parkinson’s disease experiencing mild wearing-off: a randomised, double-blind trial
- (2013) Eduardo Tolosa et al. JOURNAL OF NEURAL TRANSMISSION
- Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial
- (2013) Jeffrey Cummings et al. LANCET
- Transdermal rotigotine in early stage Parkinson's disease: A randomized, double-blind, placebo-controlled trial
- (2013) Yoshikuni Mizuno et al. MOVEMENT DISORDERS
- Association between use of benzodiazepines and risk of fractures: a meta-analysis
- (2013) D. Xing et al. OSTEOPOROSIS INTERNATIONAL
- Drug-drug interactions in a cohort of hospitalized elderly patients
- (2013) Luca Pasina et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Melatonin Prolonged Release
- (2012) Katherine A. Lyseng-Williamson DRUGS & AGING
- Drug-drug interactions at hopital admission in geriatric patients in a single facility: a retrospective study
- (2012) Rosalinda Sánchez-Arenas et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Assessment of appropriate medication administration for hospitalized patients with Parkinson’s disease
- (2012) Jyhgong Gabriel Hou et al. PARKINSONISM & RELATED DISORDERS
- Evaluation of drug–drug interaction screening software combined with pharmacist intervention
- (2012) Cristiano S. Moura et al. International Journal of Clinical Pharmacy
- Potentially Harmful Drug–Drug Interactions in the Elderly: A Review
- (2011) Lisa E. Hines et al. American Journal Geriatric Pharmacotherapy
- Single dose pharmacokinetics of the transdermal rotigotine patch in patients with impaired renal function
- (2011) Willi Cawello et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Psychotropic Drug-Induced Falls in Older People
- (2011) Keith D. Hill et al. DRUGS & AGING
- STOPP (Screening Tool of Older Persons Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation
- (2011) P. Gallagher et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Emergency Hospitalizations for Adverse Drug Events in Older Americans
- (2011) Daniel S. Budnitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Amantadine for Dyskinesias in Parkinson's Disease: A Randomized Controlled Trial
- (2011) Hideyuki Sawada et al. PLoS One
- Preventable hospital admissions related to medication (HARM): Cost analysis of the HARM study
- (2011) Anne J. Leendertse et al. VALUE IN HEALTH
- Citalopram versus other antidepressants for late-life depression: a systematic review and meta-analysis
- (2010) Dallas P. Seitz et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Influence of ageing on the pharmacokinetics of levodopa in elderly patients with Parkinson’s disease
- (2010) Hiroshi Nagayama et al. PARKINSONISM & RELATED DISORDERS
- Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson's disease
- (2010) Daniel Truong Clinical Interventions in Aging
- The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia
- (2009) Remy Luthringer et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Prevalence of Frailty in Middle-Aged and Older Community-Dwelling Europeans Living in 10 Countries
- (2009) B. Santos-Eggimann et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis
- (2009) Herbert Y Meltzer et al. NEUROPSYCHOPHARMACOLOGY
- Escitalopram in the Acute Treatment of Depressed Patients Aged 60 Years or Older
- (2007) Anjana Bose et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Apomorphine for the acute treatment of “off” episodes in Parkinson's disease
- (2007) Mark Stacy et al. PARKINSONISM & RELATED DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search